Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Gu, Muxin  [Clear All Filters]
2024
Guo J, Walter K, Quiros PM, Gu M, E Baxter J, Danesh J, Di Angelantonio E, Roberts D, Guglielmelli P, Harrison CN, et al. Inherited polygenic effects on common hematological traits influence clonal selection on JAK2 and the development of myeloproliferative neoplasms. Nat Genet. 2024.
2023
Gu M, Kovilakam SCheloor, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, et al. Author Correction: Multiparameter prediction of myeloid neoplasia risk. Nat Genet. 2023.
Stelmach P, Richter S, Sauer S, Fabre MA, Gu M, Rohde C, Janssen M, Liebers N, Proynova R, Weinhold N, et al. Clonal hematopoiesis with and mutations impairs regeneration in autologous stem cell transplant recipients. Haematologica. 2023.
Gu M, Kovilakam SCheloor, Dunn WG, Marando L, Barcena C, Mohorianu I, Smith A, Kar SP, Fabre MA, Gerstung M, et al. Multiparameter prediction of myeloid neoplasia risk. Nat Genet. 2023.
Kovilakam SCheloor, Gu M, Dunn WG, Marando L, Barcena C, Nik-Zainal S, Mohorianu I, Kar S, Fabre MAlice, Quiros PM, et al. Prevalence and significance of DDX41 gene variants in the general population. Blood. 2023.
Mikutis S, Rebelo M, Yankova E, Gu M, Tang C, Coelho AR, Yang M, Hazemi ME, de Miranda MPires, Eleftheriou M, et al. Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small Molecules. ACS Cent Sci. 2023;9(5):892-904.
2022
Zhou Y, Shalhoub RN, Rogers SN, Yu S, Gu M, Fabre MAlice, Quiros PM, Diangson A, Deng W, Anand S, et al. Clonal Hematopoiesis Is Not Significantly Associated with Covid-19 Disease Severity. Blood. 2022.
2021
Pacharne S, Dovey OM, Cooper JL, Gu M, Friedrich MJ, Rajan SS, Barenboim M, Collord G, Vijayabaskar MS, Ponstingl H, et al. SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML. Blood Adv. 2021;5(9):2412-2425.